Don’t see what you’re looking for? Use the search box on MDA’s Quest magazine.
Posted on Monday, February 4, 2013 - 09:00, By: Amy Madsen
Everyone is born, and everyone dies. What happens in between — colds and flu, cardiac problems, cancer, amyotrophic lateral sclerosis (ALS) — is anyone's guess. And people do guess. It's common — indeed, almost universal — after receiving a diagnosis for any condition to question whether...
Posted on Monday, October 1, 2012 - 09:45, By: Amy Madsen
Note: The research news featured in the October-December Research Roundup is a compilation of these MDA ALS News Online articles:
Biomarkers are needed to light the way in research and therapy development
Posted on Sunday, July 1, 2012 - 09:45, By: Other
An urgent need exists for biomarkers — biological indicators — in ALS research that can be used:
Posted on Sunday, July 1, 2012 - 09:41, By: Other
Even as some scientists work to develop animal and human cellular models of C9ORF72-related ALS (see C9ORF72 Research Models), others already are targeting the gene with experimental therapies designed to inactivate it or the repeat expansion it harbors.
Posted on Sunday, July 1, 2012 - 09:39, By: Other
Phillip Wong, professor in the departments of pathology and neuroscience at Johns Hopkins University School of Medicine in Baltimore, is working — with MDA support — to develop research mouse models of C9ORF72-related ALS.
With colleagues, he plans to use the models to study more closely the...
News about the C9ORF72 gene, National ALS Registry and Cytokinetics' experimental drug was reported at the 2012 American Academy of Neurology meeting
Posted on Friday, April 27, 2012 - 10:49, By: Amy Madsen
Among the reports given at the 2012 annual meeting of the American Academy of Neurology, being held April 21-28 in New Orleans, was information about research into amyotrophic lateral sclerosis (ALS).